Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice

Por Käenmäki, M, Tammimäki, A, Garcia-Horsman, JA, Myöhänen, T, Schendzielorz, N, Karayiorgou, M, Gogos, JA, Männistö, PT
Publicado em 2009

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner

Por Myöhänen, TT, Tenorio-Laranga, J, Jokinen, B, Vázquez-Sánchez, R, Moreno-Baylach, MJ, García-Horsman, JA, Männistö, PT
Publicado em 2011

A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

Por Myöhänen, TT, Hannula, MJ, Van Elzen, R, Gerard, M, Van Der Veken, P, García-Horsman, JA, Baekelandt, V, Männistö, PT, Lambeir, AM
Publicado em 2012